Des[2’-(1H-tetrazol-5-yl)] 2-Cyanolosartan

CAS: 114772-55-3

Ref. TR-D297670

Informação sobre produto

• Nome: Des[2’-(1H-tetrazol-5-yl)] 2-Cyanolosartan
• Sinónimos: 4'-[[2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl]- [1,1'-Biphenyl]-2-carbonitrile, 2-Butyl-4-chloro-1-[(2'-cyanobiphenyl-4-yl)methyl]-5-hydroxymethylimidazole, 4'-(2-Butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)-1,1'-biphenyl-2-carbonitrile, 2-Butyl-4-chloro-1-[(2′-cyanobiphenyl-4-yl)methyl]-5-hydroxymethylimidazole, 2-[4-[[2-Butyl-4-chloro-5-(hydroxymethyl)imidazol-1-yl]methyl]phenyl]benzonitrile, 4'-[(2-butyl-4-chloro-5-hydroxymethyl)-1H-imidazol-1-yl)methyl]-[1,1'-Biphenyl]-2-carbonitrile, 4′-(2-Butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)-1,1′-biphenyl-2-carbonitrile, [1,1′-Biphenyl]-2-carbonitrile, 4′-[[2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl]-
• CAS: 114772-55-3

Descrição

Applications Des[2’-(1H-tetrazol-5-yl)] 2-Cyanolosartan is a derivative of Losartan Potassium (L470500), a an angiotensin II antagonist and is commonly used to significantly reduce risk of new onset atrial fibrillation and associated stroke in high-risk patients.
References Madasu, S., et al.: Org. Process Res. Dev., 16, 2025 (2012); Pitt, B., et al.: The Lancet, 355, 1582 (2000); Wachtell, K., et al.: J. Am. Coll. Cardiol., 45, 712 (2005)

• Marca: TRC

Propriedades químicas

• Peso molecular: 379.88
• Fórmula: C₂₂H₂₂ClN₃O
• Cor/forma: Neat
• InChI: InChI=1S/C22H22ClN3O/c1-2-3-8-21-25-22(23)20(15-27)26(21)14-16-9-11-17(12-10-16)19-7-5-4-6-18(19)13-24/h4-7,9-12,27H,2-3,8,14-15H2,1H3
• Chave InChI: InChIKey=ABCNKIQTAGPXAQ-UHFFFAOYSA-N
• SMILES: CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2C#N)cc1